↑ Rising
Business
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
6sources
6articles
4velocity
+31%since first seen
1h agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (6)
- Biogen inks $1B RayThera buyout to bag preclinical immunology assets Fierce Biotech · 12h ago
- BIIB Stock: Biogen Strengthens Immunology Pipeline In Up To $1B RayThera Deal Stocktwits · 12h ago
- Biogen Expects to Close Deal in 3Q Moomoo · 12h ago
- Biogen (BIIB) to Acquire RayThera Inc. for Up to $1 Billion GuruFocus · 12h ago
- Biogen makes up to $1B deal for secretive anti-inflammatory biotech Endpoints News · 12h ago
- Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc. Biogen · 12h ago
Related trends
▲ Peaking
Business
Mortgage Rates Spike in Response to Fed
▲ Peaking
Business
Only 16 percent of Americans think AI will have a positive impact on society, a new study shows
▲ Peaking
Business
Anthropic, Google, Other Tech Companies Commit $915 Million to Pull Carbon Out of the Sky
▲ Peaking
Business
Netflix’s Roku loss points to bigger streaming risk
▲ Peaking
Business
Oil falls to lowest since start of Iran war after ceasefire deal signed
▲ Peaking
Business